Applied Therapeutics Inc’s filing revealed that its President and CEO Shendelman Shoshana unloaded Company’s shares for reported $1.72 million on Mar 14 ’24. In the deal valued at $5.39 per share,318,573 shares were sold. As a result of this transaction, Shendelman Shoshana now holds 3,817,814 shares worth roughly $21.27 million.
Then, Perfetti Riccardo sold 110,804 shares, generating $597,234 in total proceeds. Upon selling the shares at $5.39, the Chief Medical Officer now owns 1,031,537 shares.
Before that, Hansard Adam sold 48,871 shares. Applied Therapeutics Inc shares valued at $263,415 were divested by the Chief Commercial Officer at a price of $5.39 per share. As a result of the transaction, Hansard Adam now holds 732,919 shares, worth roughly $4.08 million.
RBC Capital Mkts initiated its Applied Therapeutics Inc [APLT] rating to an Outperform in a research note published on March 26, 2024; the price target was $12. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in late February with a ‘”an Outperform”‘ rating. Barclays also remained covering APLT and has decreased its forecast on January 04, 2022 with a “an Equal weight” recommendation from previously “an Overweight” rating. Goldman revised its rating on August 27, 2021. It rated APLT as “a Sell” which previously was an “a Neutral”.
Price Performance Review of APLT
On Tuesday, Applied Therapeutics Inc [NASDAQ:APLT] saw its stock fall -1.59% to $5.57. Over the last five days, the stock has lost -12.56%. Applied Therapeutics Inc shares have risen nearly 66.27% since the year began. Nevertheless, the stocks have risen 587.23% over the past one year. While a 52-week high of $9.39 was reached on 02/28/24, a 52-week low of $0.76 was recorded on 01/08/24. SMA at 50 days reached $5.33, while 200 days put it at $2.92. A total of 0.56 million shares were traded, compared to the trading of 3.06 million shares in the previous session.
Levels Of Support And Resistance For APLT Stock
The 24-hour chart illustrates a support level at 5.40, which if violated will result in even more drops to 5.23. On the upside, there is a resistance level at 5.72. A further resistance level may holdings at 5.88. The Relative Strength Index (RSI) on the 14-day chart is 42.21, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.71, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.55%. Stochastics %K at 13.01% indicates the stock is a buying.
How much short interest is there in Applied Therapeutics Inc?
A steep rise in short interest was recorded in Applied Therapeutics Inc stocks on Mar 15, 2024, dropping by 80000.0 shares to a total of 3.79 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 3.87 million shares. There was a decline of -2.11%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 4.06% of the overall stock float, the days-to-cover ratio (short ratio) fell to 1.05.
